Get started
Author

Javier Borja

Observed names: J Borja, J. Borja
OpenAlex ID: A5110127315
A 12‐week placebo‐controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis
2008 · S. Fantin, J. Maspero, et al. · Allergy · 60
Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study.
2005 · C Martínez-Cócera, M De Molina, et al. · PubMed · 45
Tachyphylaxis following regular use of formoterol in exercise-induced bronchospasm.
2001 · R García, P Guerra, et al. · PubMed · 42
COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study
2011 · Marc Miravitlles, Iñaki Izquierdo, et al. · Respiratory Medicine · 41
Safety of Rupatadine Administered Over a Period of 1 Year in the Treatment of Persistent Allergic Rhinitis
2009 · Antonio Valero, Fernando de la Torre, et al. · Drug Safety · 39
Oral ofloxacin versus parenteral imipenem-cilastatin in the treatment of osteomyelitis.
1999 · M Gomis, J Barberán, et al. · PubMed · 26
Cefepime versus Ceftriaxone for Empiric Treatment of Hospitalized Patients with Community-Acquired Pneumonia
1999 · Javier Borja, Francesc Jané · Antimicrobial Agents and Chemotherapy · 23
Lack of Correlation Between Lithium Pharmacokinetic Parameters Obtained from Plasma and Saliva
1988 · R. Obach, J. Borja, et al. · Therapeutic Drug Monitoring · 20
Safety of triflusal (antiplatelet drug) in patients with aspirin‐exacerbated respiratory diseases
2007 · J. Fraj, A. Valero, et al. · Allergy · 18
Aromatase Inhibitors: Clinical Pharmacology and Therapeutic Implications in Breast Cancer
1992 · N Pérez, J Borja · Journal of International Medical Research · 17
In vitro Interaction between Ofloxacin and Cefotaxime against Gram-Positive and Gram-Negative Bacteria Involved in Serious Infections
1998 · C. Gimeno, J. Borja, et al. · Chemotherapy · 16
Clopidogrel and metoprolol in myocardial infarction
2006 · Javier Borja, Olga García, et al. · The Lancet · 12
Value of effort testing and acute drug testing in the evaluation of antiarrhythmic treatment
1987 · A. B. De Luna, J. Guindo, et al. · European Heart Journal · 12
Gastrointestinal safety of triflusal solution in healthy volunteers: a proof of concept endoscopic study
2011 · Rosa M. Antonijoan, Ignasi Gich, et al. · European Journal of Clinical Pharmacology · 7
Ofloxacin versus trimethoprim-sulfamethoxazole in the treatment of patients with acute exacerbation of chronic bronchitis
1996 · Máximo E. Pérez-Gonzalvo, JoséA. Mosquera-Pestaña, et al. · Clinical Therapeutics · 7
Evaluation of the methodological quality of clinical trial protocols
1993 · C. García-Cases, A. Duque, et al. · European Journal of Clinical Pharmacology · 6
Recasting the approach to the treatment of potentially malignant ventricular arrhythmias after the cast study
1990 · A. Bayés de Luna, J. Guindo, et al. · Cardiovascular Drugs and Therapy · 6
Antithrombotic treatment in atrial fibrillation
2006 · Javier Borja, Olga García, et al. · Expert Opinion on Drug Safety · 5
PDF
[Multicenter study of resistance in enterococci. The role of teicoplanin. Spanish Group for Study and Surveillance of Resistance].
1999 · R Cisterna, K Ibarra, et al. · PubMed · 5
Triflusal versus Aspirin for the Prevention of Stroke
2007 · Antonio Culebras, Javier Borja, et al. · Progress in Neurotherapeutics and Neuropsychopharmacology · 4
Hypertrophic cardiomyopathy: Combination of β blockers and verapamil may be risky
2006 · Javier Borja, Iñaki Izquierdo, et al. · BMJ · 4
Role of low–molecular-weight heparin in the management of acute coronary syndromes
2002 · Javier Borja · Current Opinion in Cardiology · 4
Triflusal versus Aspirin for the Prevention of Stroke
2008 · Antonio Culebras, Javier Borja, et al. · Cambridge University Press eBooks · 3
Heparina de bajo peso molecular en el tratamiento de los síndromes coronarios agudos sin elevación del segmento ST: angina inestable e infarto de miocardio sin onda Q
2000 · Javier Borja, Peri Olivella · Medicina Clínica · 3
Fixed drug eruption caused by cyproterone acetate
1998 · P. A. Galindo, J. Borja, et al. · Allergy · 3
Works count: 65
Citation count: 453
H-index: 12
I10-index: 13
Year
Topic
Type